Results 241 to 250 of about 378,023 (292)
Barriers and Drivers of Using Alternative Fertilizers in Sustainable Agriculture: Case Study of Poland. [PDF]
Environ ManageMarcinek P, Smol M.
europepmc +1 more source
Advanced Emissivity Tuning Via Femtosecond Laser Surface Engineering
Advanced Optical Materials, EarlyView.Femtosecond laser surface processing (FLSP) is employed to fabricate titanium‐based metamaterials with engineered micro/nano‐scale features that exhibit spectrally selective and omnidirectional thermal emissivity. By integrating advanced ellipsometry, electromagnetic modeling, and compositional analysis, the work reveals resonance‐driven emissivity ...
Zahra Kamali Khanghah +8 more
wiley +1 more source
Patient data for commercial companies? An ethical framework for sharing patients' data with for-profit companies for research. [PDF]
J Med EthicsWinkler EC +4 more
europepmc +1 more source
Advanced Photonics Research, EarlyView.This review highlights recent advances in accelerating luminescence in nanostructures through cooperative emission, resonator coupling, and nonlocal light–matter interactions. By unifying concepts such as excitonic superradiance, superfluorescence, and the plasmonic Purcell effect, it reveals physical limits of ultrafast emission and their potential ...
Masaaki Ashida +3 more
wiley +1 more source
Polarization and rule of law crisis-insights from Poland. [PDF]
Z Vgl PolitSolska M.
europepmc +1 more source
The Constitutional Limits of EU Competition Law – United in Diversity
, 2019 Christopher Townley, Alexander H. Türk
openalex +1 more source
Hard‐Magnetic Soft Millirobots in Underactuated Systems
Advanced Robotics Research, EarlyView.This review provides a comprehensive overview of hard‐magnetic soft millirobots in underactuated systems. It examines key advances in structural design, physics‐informed modeling, and control strategies, while highlighting the interplay among these domains.
Qiong Wang +4 more
wiley +1 more source
Evaluating the corporate social responsibility agenda for high-cost novel therapies: roles for government and civil society. [PDF]
Health Res Policy SystWong A, Saeed G, Garner S, Kohler J.
europepmc +1 more source